FXYD3 and breast carcinoma: We were able to show that FXYD3 and PTX3 expression is associated with poor overall patient survival in SCC patients and LAD1, SLC7A5, SLPI, NID2, SPOCK1 and SULF1 correlated significantly with impaired pCR in breast cancer patients.